tirzepatide surmount trials SURMOUNT-1 Trial Surmount Press Briefing #ADA2022

As discussed in sections 4 and 6, such countries could achieve these targets by assigning higher priority for health in government spending, including for preventive health interventions, and having governments use subsidies and pooled procurement to ensure access to drugs, vaccines, and commodities that target the 15 priority conditions

D., & Katki, H

1-4 It belongs to the drug class of glucagon-like peptide-1 (GLP-1) receptor agonists

Co-authors of the research, Dinabel Peralta-Reich, MD, and Alexandra Filingeri DCN, RCN, explained the key findings to Medical News Today: This study measured body compositionspecifically body fat mass (in pounds), muscle mass (in pounds), and total body weight (in pounds)in patients at baseline, 3 months, and 6 months while taking GLP/GIP weight loss medications